Pharmacy World and Science

, Volume 28, Issue 2, pp 76–90 | Cite as

Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists

  • Rachel Jane HobsonEmail author
  • Graham J. Sewell
Research article


Objective (of the study)

To provide data on the views of chief pharmacists (CPs) and primary care trust pharmacists (PCTPs) on the risks and concerns surrounding supplementary prescribing.


Secondary and primary care within England.


Postal questionnaire surveys of chief pharmacists and primary care trust pharmacists.

Main Outcome Measure

Significance of the association between the extracted factors.


The response rate was 68% for both the primary care (183/271) and secondary care surveys (97/143). The survey tool was subjected to factor analysis and reliability testing. For both sectors, the three factors that were extracted described concerns over the training model for supplementary prescribing, concerns about the professional competency/responsibility of the supplementary prescribers once trained, and positivity about the implementation of supplementary prescribing. For both sectors, as trusts have more experience of supplementary prescribing by nurses, the respondents had less concerns about the supplementary prescribing training model. For secondary care, as the total number of pharmacists employed within the trust increases, the respondents had less concerns over the limitations of the supplementary prescribing training model.


Although both sectors have concerns over the training model for supplementary prescribing and also professional competence and responsibility once trainees qualify, there is overall a positive attitude towards supplementary prescribing and there is a belief that pharmacists wish to take this role on.


Supplementary Prescribing Pharmacist Factor Analysis Questionnaire Nursing Risk  United Kingdom Opinions 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



The authors would like to thank all of the pharmacists who took the time to complete the questionnaire survey, Dr Jenny Scott, lecturer in clinical pharmacy and pharmacy practice and Dr Marjorie Weiss, senior lecturer in pharmacy practice, for advice on the presentation and content of the paper, and Dr Gordon Taylor, medical statistician, for advice on statistical analysis.

This study was financially supported by the University of Bath.


  1. 1.
    Hobson RJ, Sewell GJ. Supplementary prescribing by pharmacists in England. Am J Health-Syst Pharm 2006; 63:244–253PubMedCrossRefGoogle Scholar
  2. 2.
    Nurse and pharmacist prescribing powers extended. DoH: London 2005. (WWW) (November 11th 2005)
  3. 3.
    Avery AJ, Pringle M. Extended prescribing by UK nurses and pharmacists. BMJ 2005; 331:1154–1155PubMedCrossRefGoogle Scholar
  4. 4.
    Farrell J, North-Lewis P, Cross M. Pharmacist prescribing in the United States. Pharm J 1997; 259:187–190Google Scholar
  5. 5.
    van Foppe MJ, Schulz M, Tromp TF. Pharmaceutical care, European developments in concepts, implementation, teaching and research: a review. Pharm World Sci 2004; 26:303–311CrossRefGoogle Scholar
  6. 6.
    Proposals for supplementary prescribing by nurses and pharmacists and proposed amendments to the prescription only medicines (human use) order 1997. London: MCA; 2002. p. 1–19Google Scholar
  7. 7.
    Outcome of the consultation exercise on proposals for supplementary prescribing by nurses and pharmacists. London: DoH; 2002Google Scholar
  8. 8.
    Lord S. The interface – steps towards seamless care. Hosp Pharm 1999; 6:83–84Google Scholar
  9. 9.
    Hebron B, Jay C. Pharmaceutical care for patients undergoing elective ENT surgery. Pharm J 1998; 260:65–66Google Scholar
  10. 10.
    Hick H, Deady PE, Wright D, Silcock J. The impact of the pharmacist on an elective general surgery pre-admission clinic. Pharm World Sci 2001; 23(2):65–69PubMedCrossRefGoogle Scholar
  11. 11.
    Booth CD. Pharmacist-managed anticoagulant clinics: a review. Pharm J 1998; 261:623–625Google Scholar
  12. 12.
    Cattell R, Conroy C, Sheikh A. Pharmacist intergration into the discharge process: a qualitative and quantitative impact assessment. Int J Pharm Pract 2001; 9:59–64Google Scholar
  13. 13.
    Taheny K, Tyrell A, Cairns C, Bunn R. Influence of patient focused care on managing medicines for discharge. Pharm J␣1999; 262:368–371Google Scholar
  14. 14.
    Leech D. Patient directed pharmacy services – do they benefit their patients? Hosp Pharm 2000; 7:263–264Google Scholar
  15. 15.
    Jacklin A, Patel K, Almossawi O. A discharge pharmacist service improves the timeliness, quality and cost of discharge. Pharm in Pract 2001; 11:100–102Google Scholar
  16. 16.
    Ketley D, Qualie MJ, Godfrey BD. The near patient clinical pharmacist 1. From design to pilot. Pharm J 1998; 261:247–249Google Scholar
  17. 17.
    Tabachnick BG, Fidell LS Using multivariate statistics. New York: Harper and Row; 2000. 0321189000Google Scholar
  18. 18.
    NHS executive information policy unit. Information for health: an information strategy for the modern NHS 1998–2005, a national strategy for local implementation. London: DOH; 1998Google Scholar
  19. 19.
    While A, Biggs KS. Benefits and challenges of nurse prescribing. J Adv Nurs 2004; 45(6):559–567PubMedCrossRefGoogle Scholar
  20. 20.
    Latter S, Rycroft-Malone J, Yerrell P, Shaw D. Evaluating educational preparation for a health education role in practice: the case of medication education. J Adv Nurs 2000; 32(5):1282–1290PubMedCrossRefGoogle Scholar
  21. 21.
    Latter S, Courtenay M. Effectiveness of nurse prescribing: a review of the literature. J Clin Nurs 2004; 13:26–32PubMedCrossRefGoogle Scholar
  22. 22.
    Dawoud D, Goodye LI, Lovejoy A, Greene RJ. Perceptions and perceived competencies of pharmacists on supplementary prescribing training courses in London and the South East. Int J Pharm Pract 2004; 12:R40Google Scholar
  23. 23.
    Antoniou S, Webb DG, Davies JG, Bates I, McRobbie D, Wright J, et al. General level competency framework improves the clinical practice of hospital pharmacists: final results of the south of England trial. Int J Pharm Pract 2004; 12:R22–R23Google Scholar
  24. 24.
    Farrar K. Time to review prescribing in hospitals by preregistration house officers. Pharm J 2002; 268:136CrossRefGoogle Scholar
  25. 25.
    No obstacle to pharmacists prescribing. Pharm J 2002; 269:450Google Scholar
  26. 26.
    While A, Mudaly M, Nathan A. Views of community pharmacists regarding supplementary prescribing. Int J␣Pharm Pract 2004; 12:R43CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  1. 1.Department of Pharmacy and PharmacologyUniversity of Bath and Swindon & Marlborough NHS TrustClaverton Down, BathUK
  2. 2.Department of PharmacyKingston University and Plymouth Hospitals NHS TrustPlymouthUK

Personalised recommendations